Andrew Gulley

Andrew Gulley is an accomplished executive with extensive experience in the pharmaceutical industry, currently serving as the Executive Director of Product Strategy at Axsome Therapeutics, Inc., where leadership of cross-functional teams has been pivotal in developing commercial strategies for Alzheimer’s Disease and Pain assets. Prior roles at Axsome included Executive Director of Commercial Strategy, where Andrew developed an international infrastructure and managed commercial operations in Canada. Experience at Novartis includes roles as Marketing Director for Pelacarsen, Regional Sales Director for Aimovig, and Director of Marketing Excellence, driving significant sales growth and brand strategy execution. Previous positions at Celgene, Sanofi Pasteur, and Ortho Dermatologics further enriched Andrew's marketing and sales expertise. Andrew holds an MBA in Finance and Business Strategy from Rutgers Business School and a Bachelor's degree in Marketing and Finance from Villanova University.